Go to the list of all blogs
Allana's Avatar
published in Blogs
Sep 24, 2026
Intuitive Machines (LUNR) vs Voyager Technologies (VOYG): Weighing Scale Against Momentum in Space and Defense

Intuitive Machines (LUNR) vs Voyager Technologies (VOYG): Weighing Scale Against Momentum in Space and Defense

Key Takeaways

  • LUNR operates at a materially larger revenue scale, with a roughly $1.8 billion backlog versus VOYG's record $275 million backlog.
  • Both companies are tied to space and defense spending, but LUNR skews toward lunar infrastructure and satellite communications, while VOYG spans defense systems, space solutions, and commercial space stations.
  • Neither company is currently profitable on a GAAP (Generally Accepted Accounting Principles) basis, making execution and backlog conversion central to each investment thesis.
  • LUNR has recently added large awards and acquisitions, while VOYG has leaned on accelerating bookings tied to defense demand.

Why This Comparison Matters Now

Space and defense equities continue to attract attention as government and commercial budgets grow around lunar exploration, satellite infrastructure, and national security. This analysis looks at LUNR and VOYG, two companies active in related but distinct parts of the aerospace sector. Both draw revenue from government and commercial customers, yet their scale, business models, and risk profiles set them apart. Investors tracking space infrastructure and defense themes may find the details helpful for assessing positioning in the current environment. I also checked this using Tickeron’s AI Screener to see how the stocks compare to others in the industry.

Intuitive Machines (LUNR) Overview and Recent Results

Intuitive Machines (LUNR) focuses on space infrastructure and services, particularly its lunar landers along with a growing satellite and communications business. The company achieved a soft landing of its Nova-C lander on the Moon in 2024 and followed up at the lunar south pole in 2025, strengthening its ties with NASA.

Recent developments include record second-quarter 2026 revenue of $206.2 million, more than 300% higher than the prior year, and a record backlog of about $1.8 billion after securing roughly $920 million in new awards. These included a $180.4 million NASA Commercial Lunar Payload Services task order and a commercial geostationary satellite contract. The company has also grown through acquisitions such as Lanteris Space Systems and the Goonhilly Earth Station and COMSAT ground-station assets, alongside a $175 million strategic equity investment. I reviewed the backlog details through Tickeron’s AI Pattern Search Engine for additional context on recent award trends.

Profitability remains a challenge, with negative adjusted EBITDA in the latest quarter partly due to fixed-price lunar mission costs. Management reaffirmed full-year 2026 revenue guidance of $900 million to $1 billion, though the stock has pulled back over the past six months as investors balance execution risks with the expanding order book.

Voyager Technologies (VOYG) Overview and Recent Results

Voyager Technologies (VOYG) is a defense and space technology firm that went public on the New York Stock Exchange in June 2025. It operates in three segments: Defense & National Security, Space Solutions, and Starlab Space Stations, with capabilities in solid propulsion, signal intelligence, and space-qualified communications systems.

Momentum has built in recent weeks. In the most recent quarter, the company reported net sales of about $35 million, bookings near $45 million, and a book-to-bill ratio of 1.3, lifting its backlog to a record $275 million, up 54% year over year. Management linked much of the demand to Golden Dome-aligned defense programs and next-generation interceptor work, and it raised full-year 2026 revenue guidance to $230 million to $255 million, implying 38% to 53% growth. Cash and equivalents stood at roughly $429 million at quarter end.

The company is still unprofitable on a GAAP basis, with a net loss in the latest quarter and a relatively small revenue base. Even so, the record backlog, rising bookings, and strong balance sheet have supported sentiment as production scales and awards convert to revenue.

Head-to-Head Comparison

The companies differ most in scale and emphasis. LUNR generates larger revenue and holds a backlog more than six times the size of VOYG's, with a primary focus on lunar access and an emerging space data network. VOYG is earlier in its growth phase but offers a broader defense-and-space mix that includes commercial space station exposure via Starlab.

Growth drivers vary as well. LUNR centers on NASA lunar missions, geostationary satellite programs, and acquisitions that expand its communications reach, while VOYG benefits from defense spending linked to Golden Dome and next-generation interceptor efforts. On the risk side, LUNR contends with execution and margin pressure from fixed-price lunar programs, whereas VOYG must navigate a small revenue base and negative margins during scaling. Both remain unprofitable on a GAAP basis, so success depends on converting backlog and achieving operating leverage rather than current earnings.

AI-Assisted Outlook

Considering factors such as trend consistency, stability, and relative positioning, Tickeron’s AI would likely point to a more favorable near-term bias for VOYG. Accelerating bookings, record backlog growth, raised guidance, and solid liquidity form a clearer momentum profile, even with the smaller revenue base. LUNR presents a larger opportunity and deeper backlog, yet recent results show margin pressure and negative adjusted EBITDA that can affect trend quality. This remains a probabilistic view, not a firm forecast; changes in execution or new catalysts could shift the relative outlook for either name.

Exploring AI Trading Bots for Sector Analysis

When evaluating names like these, I sometimes turn to Tickeron’s AI Trading Bots to review automated strategies that monitor similar aerospace and defense tickers. The platform offers a range of bots with varying timeframes and performance metrics, which can provide an additional data point alongside traditional research. This approach helps me cross-check momentum signals without replacing fundamental analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LUNR, VOYG

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


LUNR in +16.67% Uptrend, growing for three consecutive days on September 22, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where LUNR advanced for three days, in 174 of 205 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 21, 2026. You may want to consider a long position or call options on LUNR as a result. In 58 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.

The Moving Average Convergence Divergence (MACD) for LUNR just turned positive on September 21, 2026. Looking at past instances where LUNR's MACD turned positive, the stock continued to rise in 27 of 45 cases over the following month. The odds of a continued upward trend are 60%.

LUNR moved above its 50-day moving average on September 21, 2026 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The 10-day RSI Indicator for LUNR moved out of overbought territory on August 18, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 46 similar instances where the indicator moved out of overbought territory. In 38 of the 46 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 10-day moving average for LUNR crossed bearishly below the 50-day moving average on September 03, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 73%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LUNR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

LUNR broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for LUNR entered a downward trend on September 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (6.563). P/E Ratio (8.058) is within average values for comparable stocks, (59.608). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.576). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (3.940) is also within normal values, averaging (18.155).

The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. LUNR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LUNR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.67B. The market cap for tickers in the group ranges from 4.49 to 2T. SPCX holds the highest valuation in this group at 2T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -0%. For the same Industry, the average monthly price growth was -9%, and the average quarterly price growth was -2%. BETA experienced the highest price growth at 20%, while VWAV experienced the biggest fall at -24%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was -21%. For the same stocks of the Industry, the average monthly volume growth was 7% and the average quarterly volume growth was -15%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 45
P/E Growth Rating: 70
Price Growth Rating: 62
SMR Rating: 77
Profit Risk Rating: 74
Seasonality Score: 11 (-100 ... +100)
View a ticker or compare two or three
LUNR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Industry
N/A
Address
13467 Columbia Shuttle Street
Phone
+1 281 520-3703
Employees
525
Web
https://www.intuitivemachines.com
Interact to see
Advertisement
BAK shares fell roughly 11% in the latest trading session, marking a sharp single-day drop for the Brazilian petrochemical producer The decline comes amid persistent concerns about high leverage, a weaker credit profile, and soft petrochemical margins in a challenging macro environment for chemicals​
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
Intuitive Machines (LUNR) vs Voyager Technologies (VOYG): Weighing Scale Against Momentum in Space and Defense